ABBV
AbbVie Inc.
$227.38
+0.16%
Price vs EBITDA Yield
Current Valuation
- EBITDA Yield
- 3.69%
- EV/EBITDA
- 27.1x
- P/E Ratio
- 96.2x
- PEG Ratio
- 0.54
EV/EBITDA Averages
- Median (Fair Value)
- 25.5x
- Industry (Damodaran)
- 15.2x
- 1-Year Avg
- 27.1x
- 3-Year Avg
- 27.2x
- 5-Year Avg
- 27.5x
- Min / Max
- 20.3x / 29.2x
EBITDA Growth
- YoY Growth
- -13.2%
- 3-Year CAGR
- -14.6%
- 5-Year CAGR
- 4.0%
- Current Margin
- 26.5%
Financial Snapshot
- Market Cap
- $401.39B
- Enterprise Value
- $463.63B
- Revenue (TTM)
- $61.16B
- Dividend Yield
- 2.92%
Valuation Context
vs 5-Year Average
-1%
Near average
EBITDA Yield
3.69%
Moderate yield
vs Industry (Drugs (Pharmaceutica...)
78%
Above industry avg
Data Points
250
daily data points